Biological
Pentacel clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 3
- first study started
- 2003
How studies write it
Studies that test it under each name
Name
Studies by the year they started
5 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 3
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 1
Sanofi Pasteur, a Sanofi Company (3) · The Hospital for Sick Children (1) · Sanofi (1)
Often tested with
Tested in the same studies.
Diphtheria-Tetanus-acellular Pertussis Vaccines (1) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · Vaxelis (1) · Hepatitis B Vaccines (1) · Rotavirus Vaccines (1) · Measles-Mumps-Rubella Vaccine (1) · Chickenpox Vaccine (1)
Studies
Open first, then newest update. How each study uses pentacel is read from its arms, and is right about nine times in ten.
Testing it · 5
- Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and ToddlersTerminatedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT06397768Written as Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine
- Safety and Immune Response of Different Pediatric Combination Vaccines.CompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT00255047Written as Pentacel®: DTaP-IPV/Hib combined
- Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®CompletedPhase 2Sanofi Pasteur, a Sanofi CompanyNCT00362427Written as Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC
- Does the Order in Which Vaccines Are Administered Affect Pain Response?CompletedPhase 4The Hospital for Sick ChildrenNCT00390130Written as Pentacel (DPTaP+Hib)
- Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™CompletedPhase 3SanofiNCT00772928Written as Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®
Given in every arm · 6 — pentacel is usual care beside what is tested
- Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the USCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT03537508Written as DTaP-IPV//Hib vaccine
- Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)CompletedPhase 3Merck Sharp & Dohme LLCNCT03893448Written as Pentacel™
- A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)CompletedPhase 3Merck Sharp & Dohme LLCNCT03620162Written as Pentacel™
- A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and ToddlersCompletedPhase 2Sanofi Pasteur, a Sanofi CompanyNCT01049035Written as Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine Combined (DTaP-IPV/Hib combined)
- A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)CompletedPhase 3Merck Sharp & Dohme LLCNCT01340937Written as PENTACEL™
- Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.CompletedPhase 2GlaxoSmithKlineNCT00729001Written as Pentacel
As the comparator · 6 — what is tested is compared with pentacel
- Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy InfantsCompletedPhase 3GlaxoSmithKlineNCT02096263Written as Pentacel
- Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)CompletedPhase 3Merck Sharp & Dohme LLCNCT01337167Written as PENTACEL™
- Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy InfantsCompletedPhase 3GlaxoSmithKlineNCT01000974Written as Pentacel™
- Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of AgeCompletedPhase 4Sanofi Pasteur, a Sanofi CompanyNCT01659996Written as Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate
- A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)CompletedPhase 2Merck Sharp & Dohme LLCNCT00551915Written as PENTACEL™
- Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended VaccineCompletedPhase 3SanofiNCT00662870Written as Pentacel: DTaP-IPV/Hib